Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus

Pediatr Int. 2017 Mar;59(3):362-363. doi: 10.1111/ped.13193.

Authors

Nobuyuki Tetsuka¹, Takashi Yaguchi², Hiroyuki Machida³, Shuichi Ito³, Isao Miyairi¹

Affiliations

¹ Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
² Medical Mycology Research Center, Chiba University, Chiba, Japan.
³ Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.

PMID: 28317305
DOI: 10.1111/ped.13193

No abstract available

Keywords: Aspergillus lentulus; child; immunocompromised; invasive pulmonary aspergillosis; micafungin.

Publication types

Case Reports

MeSH terms

Antifungal Agents / pharmacology
Antifungal Agents / therapeutic use*
Aspergillus / drug effects*
Aspergillus / isolation & purification
Child
Drug Resistance, Fungal*
Echinocandins / therapeutic use*
Humans
Invasive Pulmonary Aspergillosis / diagnosis*
Invasive Pulmonary Aspergillosis / drug therapy
Invasive Pulmonary Aspergillosis / microbiology
Lipopeptides / therapeutic use*
Male
Micafungin
Voriconazole / pharmacology
Voriconazole / therapeutic use*

Substances

Antifungal Agents
Echinocandins
Lipopeptides
Voriconazole
Micafungin